Sees FY25 gross margin to range between 73%-75%. Sees FY25 total operating expenses to range between $92M-$95M, including approximately $11M in stock-based compensation, a noncash expense
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NPCE:
- NPCE Upcoming Earnings Report: What to Expect?
- NeuroPace’s Strong Market Position and Growth Potential Justify Buy Rating Amid Tariff Stability
- NeuroPace Expects Minimal Impact from Trade Tariffs
- NeuroPace expects minimal impact from tariffs
- NeuroPace announces data from long-term post-approval study of RNS System